MacDougall Biomedical Communications

Build Credibility and Liquidity on Wall St.

MBI has a seasoned investor relations team that has helped over 22 companies go public and a proven track record of building or restoring credibility with investors and analysts.

Learn more >>

Branding and Positioning are the Keys to Long-term Success

MacDougall Biomedical Communications specializes in branding and rebranding private and public life science companies. A clear and consistent corporate message is the keystone to a successful communications plan.

Learn more >>

Get Your Message to the Right Audience at the Right Time

MBI monitors and evaluates important industry events to proactively secure opportunities for its clients.

Learn more >>

Building Visibility & Valuation for the Life Sciences Industry

MacDougall Biomedical Communications brings a fresh, strategic approach to building visibility and valuation for its clients within the biotechnology, medical device, and life science industries.

Learn more >>

Amplify Your Success Around the Globe

MBI's media team has the skills and relationships with national and international print, online and broadcast media to get your story told.

Learn more >>

Build Credibility and Liquidity on Wall St.

MBI has a seasoned investor relations team and a proven track record of building or restoring credibility with investors and analysts.

Learn more >>

Branding and Positioning are the Keys to Long-term Success

Learn more >>

Get Your Message to the Right Audience at the Right Time

MBI monitors and evaluates important industry events to proactively secure opportunities for its clients.

Learn more >>

Building Visibility & Valuation for the Life Sciences Industry

MacDougall Biomedical Communications brings a fresh, strategic approach to building visibility and valuation for its clients within the biotechnology, medical device, and life science industries.

Learn more >>

Amplify Your Success Around the Globe

MBI's media team has the skills and relationships with national and international print, online and broadcast media to get your story told.

Learn more >>

		MacDougall Biomedical Communications' sole focus is to fulfill the unique communications needs of companies and organizations that are developing products or services within the life sciences industry. Our client profiles include: Private and public biotechnology companies Global and specialty pharmaceutical companies Medical device and diagnostic companies Universities and research institutions National and international biotechnology industry organizations International economic development organizations Organizations providing support services/products for the life sciences industry The team at MBI prides itself on being innovative and creative with a direct, honest and results-oriented approach.		8/24/2010 Roche and Aileron Enter Multi-target Alliance to Develop Stapled Peptide Drugs for Diseases across Multiple Therapeutic Areas 8/20/2010 Anchor Therapeutics Secures $10 Million Series B Financing to Advance Pepducin Drug Candidates 7/29/2010 Helicos Announces Nature Publication on First Evidence of RNA Copying Mechanisms in Human Cells more > BioPharm America (EBD Group) Boston, MA September 15-17, 2010 BIO Investor Forum San Francisco, CA October 5-6, 2010 more > more >